Delta4 receives European patents for two compounds as candidate treatments for focal segmental glomerulosclerosis: Vienna, Austria Monday, February 3, 2025, 18:00 Hrs [IST] Delta4 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback